Table of Contents
International Journal of Family Medicine
Volume 2014 (2014), Article ID 138016, 10 pages
http://dx.doi.org/10.1155/2014/138016
Review Article

Relevance of Chronic Lyme Disease to Family Medicine as a Complex Multidimensional Chronic Disease Construct: A Systematic Review

1Department of Family Medicine & Chronic Care, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium
2Department of General Practice and University Hospitals Leuven, Katholieke Universiteit Leuven (KUL), Kapucijnenvoer 33, 3000 Leuven, Belgium

Received 11 July 2014; Accepted 12 November 2014; Published 24 November 2014

Academic Editor: Christos D. Lionis

Copyright © 2014 Liesbeth Borgermans et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Krupka, K. Zachova, E. Weigl, and M. Raska, “Prevention of lyme disease: promising research or sisyphean task?” Archivum Immunologiae et Therapiae Experimentalis, vol. 59, no. 4, pp. 261–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. K. L. Clark, B. F. Leydet, and C. Threlkeld, “Geographical and genospecies distribution of borrelia burgdorferi sensu lato DNA detected in humans in the USA,” Journal of Medical Microbiology, vol. 63, no. 5, pp. 674–684, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Lewandowska, Z. Kruba, and R. Filip, “Epidemiology of Lyme disease among workers of forest inspectorates in Poland,” Annals of Agricultural and Environmental Medicine, vol. 20, no. 2, pp. 329–331, 2013. View at Google Scholar · View at Scopus
  4. G. Biesiada, J. Czepiel, M. R. Leśniak, A. Garlicki, and T. Mach, “Lyme disease: review,” Archives of Medical Science, vol. 8, no. 6, pp. 978–982, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Coburn, J. Leong, and G. Chaconas, “Illuminating the roles of the Borrelia burgdorferi adhesins,” Trends in Microbiology, vol. 21, no. 8, pp. 372–379, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. C. A. Brissette, E. D. Kees, M. M. Burke, R. A. Gaultney, A. M. Floden, and J. A. Watt, “The multifaceted responses of primary human astrocytes and brain microvascular endothelial cells to the Lyme disease spirochete, Borrelia burgdorferi,” ASN neuro, vol. 5, no. 3, pp. 221–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. T. M. Jares, M. A. Mathiason, and T. J. Kowalski, “Functional outcomes in patients with Borrelia burgdorferi reinfection,” Ticks and Tick-Borne Diseases, vol. 5, no. 1, pp. 58–62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Johnson, S. Wilcox, J. Mankoff, and R. B. Stricker, “Severity of chronic lyme disease compared to other chronic conditions: a quality of life survey,” PeerJ, vol. 2, article e322, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. World Health Organization, Regional Office for Europe, E. Lindgren, and T. Jaenson, Lyme Borreliosis in Europe: Influences and Climate Change, Epidemiology, Ecology and Adpatation Measures, World Health Organization, Regional Office for Europe, 2006.
  10. S. W. Dubrey, A. Bhatia, S. Woodham, and W. Rakowicz, “Lyme disease in the United Kingdom,” Postgraduate Medical Journal, vol. 90, no. 1059, pp. 33–42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Perronne, “Lyme and associated tick-borne diseases: global challenges in the context of a public health threat,” Frontiers in Cellular and Infection Microbiology, vol. 4, p. 74, 2014. View at Publisher · View at Google Scholar
  12. P. Stefanoff, H. Orliková, V. Príkazský, C. Bene, and M. Rosińska, “Cross-border surveillance differences: tick-borne encephalitis and lyme borreliosis in the Czech Republic and Poland, 1999–2008,” Central European Journal of Public Health, vol. 22, no. 1, pp. 54–59, 1999. View at Google Scholar
  13. K. Vanthomme, N. Bossuyt, N. Boffin, and V. van Casteren, “Incidence and management of presumption of Lyme borreliosis in Belgium: recent data from the sentinel network of general practitioners,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 31, no. 9, pp. 2385–2390, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Radzišauskiene, A. Ambrozaitis, and E. Marciuškiene, “Delayed diagnosis of lyme neuroborreliosis presenting with abducens neuropathy without intrathecal synthesis of Borrelia antibodies,” Medicina, vol. 49, no. 2, pp. 89–94, 2013. View at Google Scholar · View at Scopus
  15. A. Ali, L. Vitulano, R. Lee, T. R. Weiss, and E. R. Colson, “Experiences of patients identifying with chronic Lyme disease in the healthcare system: a qualitative study,” BMC Family Practice, vol. 15, no. 1, article 79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. Palmieri, S. King, M. Case, and A. Santo, “Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia,” International Medical Case Reports Journal, vol. 6, no. 1, pp. 99–105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. J. Halperin, “Lyme disease: neurology, neurobiology, and behavior,” Clinical Infectious Diseases, vol. 58, no. 9, pp. 1267–1272, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. N. Aucott, L. A. Crowder, and K. B. Kortte, “Development of a foundation for a case definition of post-treatment Lyme disease syndrome,” International Journal of Infectious Diseases, vol. 17, no. 6, pp. e443–e449, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. N. Aucott, A. Seifter, and A. W. Rebman, “Probable late lyme disease: a variant manifestation of untreated Borrelia burgdorferi infection,” BMC Infectious Diseases, vol. 12, article 173, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Dryden, K. Saeed, S. Ogborn, and P. Swales, “Lyme borreliosis in southern United Kingdom and a case for a new syndrome, chronic arthropod-borne neuropathy,” Epidemiology and Infection, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Embers, S. W. Barthold, J. T. Borda et al., “Persistence of borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection,” PLoS ONE, vol. 7, no. 1, Article ID e29914, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Yrjänäinen, J. Hytönen, P. Hartiala, J. Oksi, and M. K. Viljanen, “Persistence of borrelial DNA in the joints of Borrelia burgdorferi-infected mice after ceftriaxone treatment,” APMIS, vol. 118, no. 9, pp. 665–673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R. K. Straubinger, B. A. Summers, Y.-F. Chang, and M. J. G. Appel, “Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment,” Journal of Clinical Microbiology, vol. 35, no. 1, pp. 111–116, 1997. View at Google Scholar · View at Scopus
  24. E. Baum, F. Hue, and A. G. Barbour, “Experimental infections of the reservoir species Peromyscus leucopus with diverse strains of Borrelia burgdorferi, a Lyme disease agent,” mBio, vol. 3, no. 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Preac Mursic, E. Patsouris, B. Wilske, S. Reinhardt, B. Gross, and P. Mehraein, “Persistence of Borrelia burgdorferi and histopathological alterations in experimentally infected animals. A comparison with histopathological findings in human Lyme disease,” Infection, vol. 18, no. 6, pp. 332–341, 1990. View at Publisher · View at Google Scholar · View at Scopus
  26. P. S. Hefty, C. S. Brooks, A. M. Jett et al., “OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients,” Journal of Clinical Microbiology, vol. 40, no. 11, pp. 4256–4265, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Hodzic, D. Imai, S. Feng, and S. W. Barthold, “Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice,” PLoS ONE, vol. 9, no. 1, Article ID e86907, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. W. Barthold, E. Hodzic, D. M. Imai, S. Feng, X. Yang, and B. J. Luft, “Ineffectiveness of tigecycline against persistent Borrelia burgdorferi,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 2, pp. 643–651, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. L. K. Bockenstedt, D. G. Gonzalez, A. M. Haberman, and A. A. Belperron, “Spirochete antigens persist near cartilage after murine Lyme borreliosis therapy,” The Journal of Clinical Investigation, vol. 122, no. 7, pp. 2652–2660, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Hodzic, S. Feng, K. Holden, K. J. Freet, and S. W. Barthold, “Persistence of Borrelia burgdorferi following antibiotic treatment in mice,” Antimicrobial Agents and Chemotherapy, vol. 52, no. 5, pp. 1728–1736, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Yrjänäinen, J. Hytönen, X.-Y. R. Song, J. Oksi, K. Hartiala, and M. K. Viljanen, “Anti-tumor necrosis factor-α treatment activates Borrelia burgdorferi spirochetes 4 weeks after ceftriaxone treatment in C3H/He mice,” Journal of Infectious Diseases, vol. 195, no. 10, pp. 1489–1496, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. R. B. Stricker and L. Johnson, “Borrelia burgdorferi aggrecanase activity: more evidence for persistent infection in Lyme disease,” Frontiers in Cellular and Infection Microbiology, vol. 3, p. 40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Hansen, C. Crone, and W. Kristoferitsch, “Lyme neuroborreliosis,” Handbook of Clinical Neurology, vol. 115, pp. 559–575, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. R. B. Stricker and L. Johnson, “Chronic lyme disease: liberation from lyme denialism,” The American Journal of Medicine, vol. 126, no. 8, pp. e13–e14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Berndtson, “Review of evidence for immune evasion and persistent infection in Lyme disease,” International Journal of General Medicine, vol. 6, pp. 291–306, 2013. View at Google Scholar
  36. E. Jacek, B. A. Fallon, A. Chandra, M. K. Crow, G. P. Wormser, and A. Alaedini, “Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits,” Journal of Neuroimmunology, vol. 255, no. 1-2, pp. 85–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Li, G. A. McHugh, N. Damle, V. K. Sikand, L. Glickstein, and A. C. Steere, “Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis,” Arthritis and Rheumatism, vol. 63, no. 8, pp. 2238–2247, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. D. F. Battafarano, J. A. Combs, R. J. Enzenauer, and J. E. Fitzpatrick, “Chronic septic arthritis caused by Borrelia burgdorferi,” Clinical Orthopaedics and Related Research, no. 297, pp. 238–241, 1993. View at Google Scholar · View at Scopus
  39. J. Oksi, M. Marjamäki, J. Nikoskelainen, and M. K. Viljanen, “Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis,” Annals of Medicine, vol. 31, no. 3, pp. 225–232, 1999. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Pícha, L. Moravcová, D. Holečková et al., “Examination of specific DNA by PCR in patients with different forms of Lyme borreliosis,” International Journal of Dermatology, vol. 47, no. 10, pp. 1004–1010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Priem, G. R. Burmester, T. Kamradt, K. Wolbart, M. G. Rittig, and A. Krause, “Detection of Borrelia burgdorferi by polymerase chain reaction in synovial membrane, but not in synovial fluid from patients with persisting lyme arthritis after antibiotic therapy,” Annals of the Rheumatic Diseases, vol. 57, no. 2, pp. 118–121, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Miklossy, “Chronic or late lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis,” The Open Neurology Journal, vol. 6, pp. 146–157, 2012. View at Publisher · View at Google Scholar
  43. J. Miklossy, S. Donta, K. Mueller, O. Nolte, and G. Perry, “Chronic or late lyme neuroborreliosis: present and future,” The Open Neurology Journal, vol. 6, p. 78, 2012. View at Google Scholar
  44. A. Bhattacharjee, J. S. Oeemig, R. Kolodziejczyk et al., “Structural basis for complement evasion by lyme disease pathogen Borrelia burgdorferi,” The Journal of Biological Chemistry, vol. 288, no. 26, pp. 18685–18695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. C.-Y. Huang, Y.-W. Chen, T.-H. Kao et al., “Hyperbaric oxygen therapy as an effective adjunctive treatment for chronic Lyme disease,” Journal of the Chinese Medical Association, vol. 77, no. 5, pp. 269–271, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. J. N. Aucott, A. W. Rebman, L. A. Crowder, and K. B. Kortte, “Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?” Quality of Life Research, vol. 22, no. 1, pp. 75–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. U. Ljøstad and Å. Mygland, “Chronic Lyme; diagnostic and therapeutic challenges,” Acta Neurologica Scandinavica, vol. 127, no. 196, pp. 38–47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Vrethem, M. Widhe, J. Ernerudh, U. Garpmo, and P. Forsberg, “Clinical, diagnostic and immunological characteristics of patients with possible neuroborreliosis without intrathecal Ig-synthesis against borrelia antigen in the cerebrospinal fluid,” Neurology International, vol. 3, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. R. C. Bransfield, “The psychoimmunology of lyme/tick-borne diseases and its association with neuropsychiatric symptoms,” The Open Neurology Journal, vol. 6, pp. 88–93, 2012. View at Publisher · View at Google Scholar
  50. C. Sordet, “Chronic lyme disease: fact or fiction?” Joint Bone Spine, vol. 81, no. 2, pp. 110–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. P. M. Lantos, P. G. Auwaerter, and G. P. Wormser, “A systematic review of borrelia burgdorferi morphologic variants does not support a role in chronic lyme disease,” Clinical Infectious Diseases, vol. 58, no. 5, pp. 663–671, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. M. S. Klempner, P. J. Baker, E. D. Shapiro et al., “Treatment trials for post-Lyme disease symptoms revisited,” The American Journal of Medicine, vol. 126, no. 8, pp. 665–669, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. P. G. Auwaerter and M. T. Melia, “Bullying Borrelia: when the culture of science is under attack,” Transactions of the American Clinical and Climatological Association, vol. 123, pp. 79–8990, 2012. View at Google Scholar · View at Scopus
  54. P. M. Lantos, “Chronic Lyme disease: the controversies and the science,” Expert Review of Anti-Infective Therapy, vol. 9, no. 7, pp. 787–797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Sjöwall, A. Ledel, J. Ernerudh, C. Ekerfelt, and P. Forsberg, “Doxycycline-mediated effects on persistent symptoms and systemic cytokine responses post-neuroborreliosis: a randomized, prospective, cross-over study,” BMC Infectious Diseases, vol. 12, article 186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. A. W. Rebman, L. A. Crowder, A. Kirkpatrick, and J. N. Aucott, “Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients,” Clinical Rheumatology, 2014. View at Publisher · View at Google Scholar
  57. S. T. Donta, “Issues in the diagnosis and treatment of lyme disease,” The Open Neurology Journal, vol. 6, pp. 140–145, 2012. View at Publisher · View at Google Scholar
  58. L. Borgermans, B. Vrijhoef, J. Vandevoorde, J. De Maeseneer, J. Vansintejan, and D. Devroey, “Relevance of hypersexual disorder to family medicine and primary care as a complex multidimensional chronic disease construct,” International Journal of Family Medicine, vol. 2013, Article ID 519265, 5 pages, 2013. View at Publisher · View at Google Scholar
  59. L. Borgermans, J. de Maeseneer, H. Wollersheim, B. Vrijhoef, and D. Devroey, “A theoretical lens for revealing the complexity of chronic care,” Perspectives in Biology and Medicine, vol. 56, no. 2, pp. 289–299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. H. I. Huppertz, P. Bartmann, U. Heininger et al., “Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the committee for infectious diseases and vaccinations of the german academy for pediatrics and adolescent health,” European Journal of Pediatrics, vol. 171, no. 11, pp. 1619–1624, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. T. C. Wilson, A. Legler, K. C. Madison, J. A. Fairley, and B. L. Swick, “Erythema migrans: a spectrum of histopathologic changes,” The American Journal of Dermatopathology, vol. 34, no. 8, pp. 834–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. C. L. Coulon and D. Landin, “Lyme disease as an underlying cause of supraspinatus tendinopathy in an overhead athlete,” Physical Therapy, vol. 92, no. 5, pp. 740–747, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. G. P. Wormser, A. T. Tang, N. R. Schimmoeller et al., “Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa,” Medical Microbiology and Immunology, vol. 203, no. 1, pp. 65–71, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. M. D. Halpern, C. R. Molins, M. Schriefer, and M. W. Jewett, “Simple objective detection of human Lyme disease infection using immuno-PCR and a single recombinant hybrid antigen,” Clinical and Vaccine Immunology, vol. 21, no. 8, pp. 1094–1105, 2014. View at Google Scholar
  65. M. Elamin, T. Monaghan, G. Mulllins et al., “The clinical spectrum of lyme neuroborreliosis,” Irish Medical Journal, vol. 103, no. 2, pp. 46–49, 2010. View at Google Scholar · View at Scopus
  66. K. Chan, S. A. Marras, and N. Parveen, “Sensitive multiplex PCR assay to differentiate Lyme spirochetes and emerging pathogens Anaplasma phagocytophilum and Babesia microti,” BMC Microbiology, vol. 13, article 295, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. Y. Hansmann, C. Leyer, N. Lefebvre et al., “Feedback on difficulties raised by the interpretation of serological tests for the diagnosis of Lyme disease,” Medecine et Maladies Infectieuses, vol. 44, no. 5, pp. 199–205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. S. H. Lee, J. S. Vigliotti, V. S. Vigliotti, W. Jones, and D. M. Shearer, “Detection of Borreliae in archived sera from patients with clinically suspect Lyme disease,” International Journal of Molecular Sciences, vol. 15, no. 3, pp. 4284–4298, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. K. L. Clark, B. Leydet, and S. Hartman, “Lyme borreliosis in human patients in Florida and Georgia, USA,” International Journal of Medical Sciences, vol. 10, no. 7, pp. 915–931, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Mavin, E. J. Watson, and R. Evans, “Laboratory diagnosis of Lyme borreliosis in Scottish patients: a novel approach,” British Journal of Biomedical Science, vol. 71, no. 2, pp. 51–54, 2014. View at Google Scholar
  71. A. A. Noda, I. Rodríguez, B. Mondeja, and C. Fernández, “Design, optimization and evaluation of a polymerase chain reaction for detection of Borrelia spp,” Advances in Clinical and Experimental Medicine, vol. 22, no. 5, pp. 639–653, 2013. View at Google Scholar · View at Scopus
  72. M. O'Rourke, A. Traweger, L. Lusa et al., “Quantitative detection of Borrelia burgdorferi sensu lato in erythema migrans skin lesions using internally controlled duplex real time PCR,” PLoS ONE, vol. 8, no. 5, Article ID e63968, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. J. A. Branda, F. Strle, K. Strle, N. Sikand, M. J. Ferraro, and A. C. Steere, “Performance of United States serologic assays in the diagnosis of lyme borreliosis acquired in Europe,” Clinical Infectious Diseases, vol. 57, no. 3, pp. 333–340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Iyer, P. Mukherjee, K. Wang, J. Simons, G. P. Wormser, and I. Schwartz, “Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability,” Journal of Clinical Microbiology, vol. 51, no. 3, pp. 857–862, 2013. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Sapi, N. Pabbati, A. Datar, E. M. Davies, A. Rattelle, and B. A. Kuo, “Improved culture conditions for the growth and detection of Borrelia from human serum,” International Journal of Medical Sciences, vol. 10, no. 4, pp. 362–376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Nelson, S. Hojvat, B. Johnson et al., “Concerns regarding a new culture method for Borrelia burgdorferi not approved for the diagnosis of Lyme disease,” Morbidity and Mortality Weekly Report, vol. 63, no. 15, p. 333, 2014. View at Google Scholar · View at Scopus
  77. A. Wasiluk, N. Waszkiewicz, S. D. Szajda et al., “Alpha fucosidase and beta galactosidase in serum of a lyme disease patients as a possible marker of accelerated senescence—a preliminary study,” Folia Histochemica et Cytobiologica, vol. 50, no. 2, pp. 270–274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. A. B. MacDonald, “Borrelia burgdorferi tissue morphologies and imaging methodologies,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 32, no. 8, pp. 1077–1082, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. S. T. Donta, R. B. Noto, and J. A. Vento, “SPECT brain imaging in chronic lyme disease,” Clinical Nuclear Medicine, vol. 37, no. 9, pp. e219–e222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Z. Burakgazi, “Lyme disease—induced polyradiculopathy mimicking amyotrophic lateral sclerosis,” International Journal of Neuroscience, vol. 124, no. 11, pp. 859–862, 2014. View at Google Scholar
  81. C. Ciuta, “Lyme disease—unusual medical encounter for an urologist,” Revista medico-chirurgicală a Societăţii de Medici şi Naturalişţi din Iaşi, vol. 116, no. 4, pp. 1101–1105, 2012. View at Google Scholar
  82. S. J. Seligman, M. M. Petzke, and D. Bogunovic, “Pathogenesis of Post-Lyme Disease Symptoms,” Clinical Infectious Diseases, vol. 59, no. 5, p. 747, 2014. View at Google Scholar
  83. A. M. Chandra, J. G. Keilp, and B. A. Fallon, “Correlates of perceived health-related quality of life in post-treatment Lyme encephalopathy,” Psychosomatics, vol. 54, no. 6, pp. 552–559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. D. Londono, D. Cadavid, E. E. Drouin et al., “Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis,” Arthritis & Rheumatology, vol. 66, no. 8, pp. 2124–2133, 2014. View at Google Scholar
  85. G. Murillo, B. Ramírez, L. A. Romo, A. Muñoz-Sanz, D. Hileeto, and M. Calonge, “Oculopalpebral borreliosis as an unusual manifestation of Lyme disease,” Cornea, vol. 32, no. 1, pp. 87–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. T. Chmielewski, J. Brydak-Godowska, B. Fiecek et al., “Bacterial tick-borne diseases caused by Bartonella spp., Borrelia burgdorferi sensu lato, Coxiella burnetii, and Rickettsia spp. among patients with cataract surgery,” Medical Science Monitor, vol. 20, pp. 927–931, 2014. View at Google Scholar
  87. M. Manek, A. Kulkarni, and A. Viera, “Hint of lyme, an uncommon cause of syncope,” BMJ Case Reports, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. A. Maniu and L. Damian, “Rapid progressive bilateral hearing loss due to granulomatous otitis media in Lyme disease,” The American Journal of Otolaryngology—Head and Neck Medicine and Surgery, vol. 34, no. 3, pp. 245–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. O. Yossepowitch, T. Gottesman, O. Schwartz-Harari, A. Soroksky, and M. Dan, “Aseptic meningitis and adult respiratory distress syndrome caused by Borrelia persica,” Infection, vol. 40, no. 6, pp. 695–697, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. A. M. Noyes and J. Kluger, “A tale of two syndromes: Lyme disease preceding postural orthostatic tachycardia syndrome,” Annals of Noninvasive Electrocardiology, 2014. View at Publisher · View at Google Scholar · View at Scopus
  91. G. Matera, A. Labate, A. Quirino et al., “Chronic neuroborreliosis by B. garinii: an unusual case presenting with epilepsy and multifocal brain MRI lesions,” New Microbiologica, vol. 37, 393, no. 3, p. 397, 2014. View at Google Scholar
  92. J. Markeljević, H. Šarac, and M. Radoš, “Tremor, seizures and psychosis as presenting symptoms in a patient with chronic lyme neuroborreliosis (Lnb),” Collegium Antropologicum, vol. 35, supplement 1, pp. 313–318, 2011. View at Google Scholar · View at Scopus
  93. N. A. Farshad-Amacker, H. Scheffel, T. Frauenfelder, and H. Alkadhi, “Brainstem abnormalities and vestibular nerve enhancement in acute Neuroborreliosis,” BMC Research Notes, vol. 6, no. 1, article 551, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Fathi, W. W. Huang, and K. Brown, “Disseminated Lyme borreliosis preceded by hepatitis in an African American male,” Dermatology Online Journal, vol. 18, no. 10, article 4, 2012. View at Google Scholar · View at Scopus
  95. G. Cassisi, P. Sarzi-Puttini, and M. Cazzola, “Chronic widespread pain and fibromyalgia: could there be some relationship with infections and vaccinations?” Clinical and Experimental Rheumatology, vol. 29, supplement 69, no. 6, pp. S118–S126, 2011. View at Google Scholar · View at Scopus
  96. K. Iwata, T. Shimada, and H. Kawabata, “A case of lyme disease requiring over 1 year to diagnose at an infectious-disease clinic,” Kansenshōgaku zasshi, vol. 87, no. 1, pp. 44–48, 2013. View at Google Scholar · View at Scopus
  97. S. E. Schutzer, T. E. Angel, T. Liu et al., “Distinct cerebrospinal fluid proteomes differentiate post-treatment Lyme disease from Chronic fatigue syndrome,” PLoS ONE, vol. 6, no. 2, Article ID e17287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Kuhn, S. Grave, R. Bransfield, and S. Harris, “Long term antibiotic therapy may be an effective treatment for children co-morbid with Lyme disease and Autism Spectrum Disorder,” Medical Hypotheses, vol. 78, no. 5, pp. 606–615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. P. D. Glaude, A. M. Huber, T. Mailman, S. Ramsey, B. Lang, and E. Stringer, “A82: lyme arthritis: an emerging clinical problem in nova scotia, Canada,” Arthritis & Rheumatology, vol. 66, supplement 3, p. S115, 2014. View at Publisher · View at Google Scholar
  100. F. Blanc, N. Philippi, B. Cretin et al., “Lyme neuroborreliosis and dementia,” Journal of Alzheimer's Disease, vol. 41, no. 4, pp. 1087–1093, 2014. View at Google Scholar
  101. N. S. Baranova, N. N. Spirin, L. A. Nizovtzeva, Y. A. Pakhomova, and O. A. Fadeeva, “Clinical and instrumental characteristics of chronic neuroborreliosis,” Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova, vol. 112, no. 9, pp. 40–47, 2012. View at Google Scholar · View at Scopus
  102. I. Erol, B. Klçarslan, S. Saygi, Ş. Demir, and F. Alehan, “Acute transverse myelitis in a child with lyme disease and a review of literature,” Pediatric Neurology, vol. 48, no. 4, pp. 325–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. R. Banerjee, J. J. Liu, and H. M. Minhas, “Lyme neuroborreliosis presenting with alexithymia and suicide attempts,” The Journal of Clinical Psychiatry, vol. 74, no. 10, p. 981, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. L. E. Cottle, E. Mekonnen, M. B. J. Beadsworth, A. R. O. Miller, and N. J. Beeching, “Lyme disease in a British referral clinic,” QJM, vol. 105, no. 6, pp. 537–543, 2012. View at Publisher · View at Google Scholar · View at Scopus
  105. W. Berghoff, “Chronic lyme disease and co-infections: differential diagnosis,” The Open Neurology Journal, vol. 6, pp. 158–178, 2012. View at Google Scholar
  106. L. Michelet, S. Delannoy, E. Devillers et al., “High-throughput screening of tick-borne pathogens in Europe,” Frontiers in Cellular and Infection Microbiology, vol. 4, p. 103, 2014. View at Google Scholar
  107. K. Chondrogiannis, A. Vezakis, M. Derpapas, A. Melemeni, and G. Fragulidis, “Seronegative cat-scratch disease diagnosed by PCR detection of Bartonella henselae DNA in lymph node samples,” Brazilian Journal of Infectious Diseases, vol. 16, no. 1, pp. 96–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. M. H. Hersh, R. S. Ostfeld, D. J. McHenry et al., “Co-infection of blacklegged ticks with Babesia microti and Borrelia burgdorferi is higher than expected and acquired from small mammal hosts,” PLoS ONE, vol. 9, no. 6, Article ID e99348, 2014. View at Google Scholar
  109. H. W. Horowitz, M. E. Aguero-Rosenfeld, D. Holmgren et al., “Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity,” Clinical Infectious Diseases, vol. 56, no. 1, pp. 93–99, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. E. Tijsse-Klasen, H. Sprong, and N. Pandak, “Co-infection of Borrelia burgdorferi sensu lato and Rickettsia species in ticks and in an erythema migrans patient,” Parasites & Vectors, vol. 6, article 347, 2013. View at Publisher · View at Google Scholar · View at Scopus
  111. P. J. Mayne, “Emerging incidence of Lyme borreliosis, babesiosis, bartonellosis, and granulocytic ehrlichiosis in Australia,” International Journal of General Medicine, vol. 4, pp. 845–852, 2011. View at Google Scholar
  112. M. J. Middelveen, P. J. Mayne, D. G. Kahn, and R. B. Stricker, “Characterization and evolution of dermal filaments from patients with Morgellons disease,” Clinical, Cosmetic and Investigational Dermatology, vol. 6, pp. 1–21, 2013. View at Google Scholar · View at Scopus
  113. M. J. Middelveen, D. Burugu, A. Porur et al., “Association of spirochetal infection with Morgellons disease,” F1000Research, vol. 2, p. 25, 2013. View at Publisher · View at Google Scholar
  114. M. J. Middelveen and R. B. Stricker, “Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease,” Clinical, Cosmetic and Investigational Dermatology, vol. 4, pp. 167–177, 2011. View at Publisher · View at Google Scholar
  115. J. Sperling, M. Middelveen, D. Klein, and F. Sperling, “Evolving perspectives on lyme borreliosis in Canada,” The Open Neurology Journal, vol. 6, pp. 94–103, 2012. View at Google Scholar
  116. A. K. DeLong, B. Blossom, E. L. Maloney, and S. E. Phillips, “Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials,” Contemporary Clinical Trials, vol. 33, no. 6, pp. 1132–1142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  117. R. B. Stricker and L. Johnson, “Lyme disease: the next decade,” Infection and Drug Resistance, vol. 4, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. R. B. Stricker, A. K. Delong, C. L. Green et al., “Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease,” International Journal of General Medicine, vol. 4, pp. 639–646, 2011. View at Google Scholar
  119. E. Sapi, N. Kaur, S. Anyanwu et al., “Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi,” Infection and Drug Resistance, vol. 4, no. 1, pp. 97–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. A. Amedei, G. Codolo, D. Ozolins et al., “Cerebrospinal fluid T-regulatory cells recognize Borrelia burgdorferi NapA in chronic lyme borreliosis,” International Journal of Immunopathology and Pharmacology, vol. 26, no. 4, pp. 907–915, 2013. View at Google Scholar · View at Scopus
  121. M. M. Safford, J. J. Allison, and C. I. Kiefe, “Patient complexity: more than comorbidity. The vector model of complexity,” Journal of General Internal Medicine, vol. 22, no. 3, pp. 382–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. F. Strle, G. P. Wormser, P. Mead et al., “Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis,” PLoS ONE, vol. 8, no. 5, Article ID e64110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  123. J. D. Klein, S. C. Eppes, and P. Hunt, “Environmental and life-style risk factors for Lyme disease in children,” Clinical Pediatrics, vol. 35, no. 7, pp. 359–363, 1996. View at Publisher · View at Google Scholar · View at Scopus
  124. J. Franke, A. Hildebrandt, and W. Dorn, “Exploring gaps in our knowledge on Lyme borreliosis spirochaetes—updates on complex heterogeneity, ecology, and pathogenicity,” Ticks and Tick-borne Diseases, vol. 4, no. 1-2, pp. 11–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. X.-B. Ni, N. Jia, B.-G. Jiang et al., “Lyme borreliosis caused by diverse genospecies of Borrelia burgdorferi sensu lato in northeastern china,” Clinical Microbiology and Infection, vol. 20, no. 8, pp. 808–814, 2014. View at Publisher · View at Google Scholar · View at Scopus
  126. E. Baranova, P. Solov Ev, E. Panfertsev et al., “Rational design of antigens to improve the serodiagnosis of tick-borne borreliosis in central regions of Russia,” Advances in Experimental Medicine and Biology, vol. 807, pp. 9–21, 2014. View at Publisher · View at Google Scholar
  127. S. P. Solomon, E. Hilton, B. S. Weinschel, S. Pollack, and E. Grolnick, “Psychological factors in the prediction of Lyme disease course,” Arthritis Care & Research, vol. 11, no. 5, pp. 419–426, 1998. View at Publisher · View at Google Scholar · View at Scopus
  128. T. Kötter, F. A. Schaefer, M. Scherer, and E. Blozik, “Involving patients in quality indicator development—a systematic review,” Patient Preference and Adherence, vol. 7, pp. 259–268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  129. S. A. Chong, E. Abdin, C. Sherbourne et al., “Treatment gap in common mental disorders: the Singapore perspective,” Epidemiology and Psychiatric Sciences, vol. 21, no. 2, pp. 195–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. A. Koski-Jännes, T. Hirschovits-Gerz, and M. Pennonen, “Population, professional, and client support for different models of managing addictive behaviors,” Substance Use and Misuse, vol. 47, no. 3, pp. 296–308, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. L. Johnson, A. Aylward, and R. B. Stricker, “Healthcare access and burden of care for patients with Lyme disease: a large United States survey,” Health Policy, vol. 102, no. 1, pp. 64–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. A. Vojdani, F. Hebroni, Y. Raphael, J. Erde, and B. Raxlen, “Novel diagnosis of lyme disease: potential for CAM intervention,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 3, pp. 283–295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Codony, J. Alonso, J. Almansa et al., “Perceived need for mental health care and service use among adults in Western Europe: results of the ESEMeD Project,” Psychiatric Services, vol. 60, no. 8, pp. 1051–1058, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. S. Robinson, “Lyme Disease in Maine: a Comparison of NEDSS Surveillance Data and Maine Health Data Organization Hospital Discharge data,” Online Journal of Public Health Informatics, vol. 5, no. 3, p. 231, 2014. View at Google Scholar
  135. H. Wilking and K. Stark, “Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009–2012,” Ticks and Tick-Borne Diseases, vol. 5, no. 3, pp. 219–224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. J. J. Halperin, P. Baker, and G. P. Wormser, “Common misconceptions about Lyme disease,” The American Journal of Medicine, vol. 126, no. 3, pp. 264.e1–264.e7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. P. L. Solano, M. J. Mcduffie, H. B. Fagan, and K. Gifford, “Evaluation of educational interventions for three lesser-known illnesses,” Delaware Medical Journal, vol. 85, no. 6, pp. 179–185, 2013. View at Google Scholar · View at Scopus
  138. B. Henry, A. Crabtree, D. Roth, D. Blackman, and M. Morshed, “Lyme disease: knowledge, beliefs, and practices of physicians in a low-endemic area,” Canadian Family Physician, vol. 58, no. 5, pp. e289–e295, 2012. View at Google Scholar · View at Scopus
  139. A. Verbon, “The Health Council of the Netherlands' advice on Lyme disease,” Nederlands Tijdschrift voor Geneeskunde, vol. 157, no. 29, Article ID A6626, 2013. View at Google Scholar · View at Scopus
  140. R. Horowitz, Why Can't I Get Better? Solving the Mystery of Lyme and Chronic Disease, St. Martin's Press, New York, NY, USA, 1st edition, 2013.
  141. G. G. A. Pujalte and J. V. Chua, “Tick-borne infections in the United States,” Primary Care: Clinics in Office Practice, vol. 40, no. 3, pp. 619–635, 2013. View at Publisher · View at Google Scholar · View at Scopus
  142. S. L. Valente, D. Wemple, S. Ramos, S. B. Cashman, and J. A. Savageau, “Preventive behaviors and knowledge of tick-borne illnesses: results of a survey from an endemic area,” Journal of Public Health Management and Practice, 2014. View at Publisher · View at Google Scholar · View at Scopus
  143. J. M. Knoll, A. C. Ridgeway, C. M. Boogaerts, and G. A. Burket III, “Appalachian trail Hikers' ability to recognize Lyme disease by visual stimulus photographs,” Wilderness & Environmental Medicine, vol. 25, no. 1, pp. 24–28, 2014. View at Publisher · View at Google Scholar · View at Scopus